Official 2024 U.S. DOL Form 5500 summary for Karyopharm Therapeutics INC. (Karyopharm Therapeutics INC. 401(k) Plan · EIN 26-3931704 · PN 001): $55.63M net assets, 284 active participants, and $12.37 per $10,000 (12.37 bps).
| Plan Sponsor | Karyopharm Therapeutics INC. |
|---|---|
| Filing Identifier | Karyopharm Therapeutics INC. 401(k) Plan · EIN 26-3931704 · PN 001 |
| Plan Category & State | 401(k) Defined Contribution (MA) |
| Asset-Size Peer Cohort | $25M-$100M |
| Plan Net Assets (2024) | $55.63M |
| Active Participants | 284 |
| Direct Admin Fee Rate | $12.37 per $10,000 (12.37 bps) |
| Cohort Peer Median | $19.23 per $10,000 (19.23 bps) |
| Primary Recordkeeper / Provider | Fidelity Investments |
| Schedule H Line 4a Remittance | Schedule H Line 4a Late Remittance Reported ($152.00, often administrative timing) |
Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI